These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38801489)

  • 21. Structural and Practical Identifiability Issues of Immuno-Epidemiological Vector-Host Models with Application to Rift Valley Fever.
    Tuncer N; Gulbudak H; Cannataro VL; Martcheva M
    Bull Math Biol; 2016 Sep; 78(9):1796-1827. PubMed ID: 27651156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple work flow for biologically inspired model reduction--application to early JAK-STAT signaling.
    Quaiser T; Dittrich A; Schaper F; Mönnigmann M
    BMC Syst Biol; 2011 Feb; 5():30. PubMed ID: 21338487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Easy parameter identifiability analysis with COPASI.
    Schaber J
    Biosystems; 2012 Dec; 110(3):183-5. PubMed ID: 23041463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing parameter identifiability by model-based experimentation.
    Raue A; Kreutz C; Maiwald T; Klingmuller U; Timmer J
    IET Syst Biol; 2011 Mar; 5(2):120-30. PubMed ID: 21405200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifiability and estimation of multiple transmission pathways in cholera and waterborne disease.
    Eisenberg MC; Robertson SL; Tien JH
    J Theor Biol; 2013 May; 324():84-102. PubMed ID: 23333764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parameter Identifiability of Fundamental Pharmacodynamic Models.
    Janzén DL; Bergenholm L; Jirstrand M; Parkinson J; Yates J; Evans ND; Chappell MJ
    Front Physiol; 2016; 7():590. PubMed ID: 27994553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three novel approaches to structural identifiability analysis in mixed-effects models.
    Janzén DLI; Jirstrand M; Chappell MJ; Evans ND
    Comput Methods Programs Biomed; 2019 Apr; 171():141-152. PubMed ID: 27181677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finding identifiable parameter combinations in nonlinear ODE models and the rational reparameterization of their input-output equations.
    Meshkat N; Anderson C; Distefano JJ
    Math Biosci; 2011 Sep; 233(1):19-31. PubMed ID: 21763702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development.
    van Noort M; Ruppert M; DeJongh J; Marostica E; Bosch R; Mešić E; Snelder N
    CPT Pharmacometrics Syst Pharmacol; 2024 Jul; 13(7):1170-1179. PubMed ID: 38715385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis.
    Brouwer AF; Meza R; Eisenberg MC
    PLoS Comput Biol; 2017 Mar; 13(3):e1005431. PubMed ID: 28288156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical identifiability and uncertainty analysis of the one-dimensional hindered-compression continuous settling model.
    Li B; Stenstrom MK
    Water Res; 2016 Mar; 90():235-246. PubMed ID: 26734783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parameter identifiability and model selection for partial differential equation models of cell invasion.
    Liu Y; Suh K; Maini PK; Cohen DJ; Baker RE
    J R Soc Interface; 2024 Mar; 21(212):20230607. PubMed ID: 38442862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability.
    Sher A; Niederer SA; Mirams GR; Kirpichnikova A; Allen R; Pathmanathan P; Gavaghan DJ; van der Graaf PH; Noble D
    Bull Math Biol; 2022 Feb; 84(3):39. PubMed ID: 35132487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Identifiability of Dynamic Systems Biology Models.
    Villaverde AF; Barreiro A; Papachristodoulou A
    PLoS Comput Biol; 2016 Oct; 12(10):e1005153. PubMed ID: 27792726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the identifiability of metabolic network models.
    Berthoumieux S; Brilli M; Kahn D; de Jong H; Cinquemani E
    J Math Biol; 2013 Dec; 67(6-7):1795-832. PubMed ID: 23229063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local Riemannian geometry of model manifolds and its implications for practical parameter identifiability.
    Lill D; Timmer J; Kaschek D
    PLoS One; 2019; 14(6):e0217837. PubMed ID: 31158252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems.
    Garcia-Tirado J; Zuluaga-Bedoya C; Breton MD
    J Diabetes Sci Technol; 2018 Sep; 12(5):937-952. PubMed ID: 30095007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifiability of large-scale non-linear dynamic network models applied to the ADM1-case study.
    Nimmegeers P; Lauwers J; Telen D; Logist F; Impe JV
    Math Biosci; 2017 Jun; 288():21-34. PubMed ID: 28237667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.
    Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):279-92. PubMed ID: 21347679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy.
    Wu Z; Phan T; Baez J; Kuang Y; Kostelich EJ
    Math Biosci Eng; 2019 Apr; 16(5):3512-3536. PubMed ID: 31499626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.